Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care
In this episode, we speak with Theresa Shireman, PhD from Brown University School of Public Health. Dr. Shireman Dr. Shireman discusses her recent study which examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures.